| MSD Merck Sharp & Dohme AG - Winrevair 45 mg, Pulver zur Herstellung einer Injektionslösung |
| 69129 | | 01 | | Winrevair 45 mg | | Pulver zur Herstellung einer Injektionslösung | | C02KX | | Antihypertensives for Pulmonary Arterial Hypertension | | 13.09.2024 | | |
|
| Composition |
| Praeparatio cryodesiccata: sotaterceptum 45 mg, acidum citricum monohydricum, trinatrii citras dihydricus corresp. natrium 0.49 mg, polysorbatum 80, saccharum, pro vitro. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | Dry substance | | | | | | Active Agent | Dose |
|---|
| Sotaterceptum | 45 mg |
| | | | Inactive agents |
|---|
| Citric Acid Monohydrate | | Polysorbatum 80 | | Saccharum | | Trinatrii Citras Dihydricus |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | PR | PR | B | | No | | 002 | 2 | PR | PR | B | | No |
|
